Announcements Trials
Browse Landscape

Phase

Phase 2 19Phase 3 13Phase 1 7Phase NA 3Phase 2/3 2Phase 1/2 1

Status

Completed 3Unknown 2Withdrawn 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

CNS 3

Conditions

Central Nervous System Neoplasms 2Medulloblastoma 1Glioblastoma 1

Interventions

Exercise 216Blood Specimen Collection 122Surveys and Questionnaires 117Standard of Care 114Magnetic Resonance Spectroscopy 113Early Intervention, Educational 108Educational Status 102Methods 101Radiotherapy 94Radiosurgery 76Counseling 72Control Groups 64Biopsy 61Acupuncture Therapy 60Therapeutics 57Psychiatric Rehabilitation 55Resistance Training 52Saline Solution 49Cyclophosphamide 48Palliative Care 46Practice Guidelines as Topic 41Cognitive Behavioral Therapy 41Yoga 40Metformin 40Interviews as Topic 40Drug Therapy 37Surgical Procedures, Operative 36Radiofrequency Ablation 35Dexmedetomidine 35Colonoscopy 34

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase NA × Completed × Lomustine × Clear all
NCT02076152 2021-07-30

FMISO PET Study of Glioblastoma

Massachusetts General Hospital

Phase NA Completed
11 enrolled 11 charts
CNS

Glioblastoma

NCT00058370 2020-05-11

Intrathecal Radioimmunotherapy, Radiation Therapy, and Chemotherapy After Surgery in Treating Patients With Medulloblastoma

Memorial Sloan Kettering Cancer Center

Phase NA Completed
6 enrolled 8 charts
CNS

Medulloblastoma, Central Nervous System Neoplasms

NCT00303810 2014-01-28

Radiation Therapy and Combination Chemotherapy in Treating Young Patients With Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Ependymoma

Universitätsklinikum Hamburg-Eppendorf

Phase NA Completed
567 enrolled
CNS

Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡